Fast disease progression in simian HIV-infected female macaque is accompanied by a robust local inflammatory innate immune and microbial response

AIDS

Volumn 29, Issue 10, 2015, Pages F1-F8

  Ren, Wuze ^a   Ma, Yingfei ^b   Yang, Liying ^b   Gettie, Agegnehu ^a   Salas, January ^c   Russell, Kasi ^d   Blanchard, James ^d   Davidow, Amy ^e   Pei, Zhiheng ^b,f   Chang, Theresa L ^c   Cheng Mayer, Cecilia ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^d TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^f DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Gut microbiome response; Regional innate immunity; Sex disparity; Simian HIV pathogenesis

Indexed keywords

ALPHAPROTEOBACTERIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETAPROTEOBACTERIA; CONTROLLED STUDY; DELTAPROTEOBACTERIA; DISEASE COURSE; DISEASE PREDISPOSITION; EPSILONPROTEOBACTERIA; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; MALE; MICROBIAL COMMUNITY; MICROBIAL IMMUNITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEOBACTERIA; RECTUM MUCOSA; RHESUS MONKEY; SEX DIFFERENCE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIRUS LOAD; VIRUS PATHOGENESIS; ANIMAL; BIOTA; DISEASE MODEL; FECES; HUMAN; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; PATHOLOGY; RECTUM; SIMIAN IMMUNODEFICIENCY VIRUS;

CYTOKINE;

ANIMALS; BIOTA; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FECES; FEMALE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MACACA MULATTA; MALE; RECTUM; SEX FACTORS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD;

EID: 84942943632     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000711     Document Type: Article

References (43)

1. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008; 8:737-744.
2. Washburn TC, Medearis DN Jr., Childs B. Sex Differences in Susceptibility to Infections. Pediatrics 1965; 35:57-64.
3. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001; 2:777-780.
4. Garenne M. Sex differences in measles mortality: a world review. Int J Epidemiol 1994; 23:632-642.
5. Neyrolles O, Quintana-Murci L. Sexual inequality in tuberculosis. PLoS Med 2009; 6:e1000199.
6. Varkevisser CM, Lever P, Alubo O, Burathoki K, Idawani C, Moreira TM, et al. Gender and leprosy: case studies in Indonesia, Nigeria, Nepal and Brazil. Lepr Rev 2009; 80:65-76.
7. Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, Markham RB, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998; 352:1510-1514.
8. Prins M, Meyer L, Hessol NA. Sex and the course of HIV infection in the pre and highly active antiretroviral therapy eras. Aids 2005; 19:357-370.
9. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009; 15:955-959.
10. Chang JJ, Woods M, Lindsay RJ, Doyle EH, Griesbeck M, Chan ES, et al. Higher expression of several interferon-stimulated genes in HIV-1-infected females after adjusting for the level of viral replication. J Infect Dis 2013; 208:830-838.
11. Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol 2008; 1:23-30.
12. Douek DC, Roederer M, Koup RA. Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med 2009; 60: 471-484.
13. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977; 31:107-133.
14. Honda K, Littman DR. The microbiome in infectious disease and inflammation. Annu Rev Immunol 2012; 30:759-795.
15. Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012; 489:231-241.
16. Kamada N, Seo SU, Chen GY, Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013; 13:321-335.
17. Katsikis PD, Mueller YM, Villinger F. The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point? PLoS Pathog 2011; 7:e1002055.
18. Clayton JA, Collins FS. Policy: NIH to balance sex in cell and animal studies. Nature 2014; 509:282-283.
19. Goulder PJ, Watkins DI. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2008; 8:619-630.
20. Ren W, Mumbauer A, Gettie A, Seaman MS, Russell-Lodrigue K, Blanchard J, et al. Generation of lineage-related, mucosally transmissible subtype C R5 simian-human immunodeficiency viruses capable of AIDS development, induction of neurological disease, and coreceptor switching in rhesus macaques. J Virol 2013; 87:6137-6149.
21. Nossa CW, Oberdorf WE, Yang L, Aas JA, Paster BJ, Desantis TZ, et al. Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome. World J Gastroenterol 2010; 16:4135-4144.
22. Liang KY, Scott L. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22.
23. Sankaran-Walters S, Macal M, Grishina I, Nagy L, Goulart L, Coolidge K, et al. Sex differences matter in the gut: effect on mucosal immune activation and inflammation. Biol Sex Differ 2013; 4:10.
24. McKenna P, Hoffmann C, Minkah N, Aye PP, Lackner A, Liu Z, et al. The macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. PLoS Pathog 2008; 4:e20.
25. Handley SA, Thackray LB, Zhao G, Presti R, Miller AD, Droit L, et al. Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome. Cell 2012; 151:253-266.
26. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12:R60.
27. Klein SL, Poland GA. Personalized vaccinology: one size and dose might not fit both sexes. Vaccine 2013; 31:2599-2600.
28. Hirao LA, Grishina I, Bourry O, Hu WK, Somrit M, Sankaran-Walters S, et al. Early mucosal sensing of SIV infection by paneth cells induces IL-1beta production and initiates gut epithelial disruption. PLoS Pathog 2014; 10:e1004311.
29. Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Interferon-gamma and tumor necrosis factor-Alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 2005; 166:409-419.
30. Brenchley JM, PaiardiniM, Knox KS, Asher AI, Cervasi B, Asher TE, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008; 112:2826-2835.
31. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859-870.
32. Raffatellu M, Santos RL, Verhoeven DE, George MD, Wilson RP, Winter SE, et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008; 14:421-428.
33. Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ, et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med 2013; 5:193ra191.
34. Dillon SM, Lee EJ, Kotter CV, Austin GL, Dong Z, HechtDK, et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol 2014; 7:983-994.
35. Dinh DM, Volpe GE, Duffalo C, Bhalchandra S, Tai AK, Kane AV, et al. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J Infect Dis 2015; 211:19-27.
36. Mutlu EA, Keshavarzian A, Losurdo J, Swanson G, Siewe B, Forsyth C, et al. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog 2014; 10: e1003829.
37. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104:13780-13785.
38. Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol 2012; 9:219-230.
39. Winter SE, Lopez CA, Baumler AJ. The dynamics of gut-Associated microbial communities during inflammation. EMBO Rep 2013; 14:319-327.
40. Ellis CL, Ma ZM, Mann SK, Li CS, Wu J, Knight TH, et al. Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation. J Acquir Immune Defic Syndr 2011; 57:363-370.
41. Livingston RS, Myles MH, Livingston BA, Criley JM, Franklin CL. Sex influence on chronic intestinal inflammation in Helicobacter hepaticus-infected A/JCr mice. Comp Med 2004; 54:301-308.
42. Karim SS, Ramjee G. Anal sex and HIV transmission in women. Am J Public Health 1998; 88:1265-1266.
43. Misegades L, Page-Shafer K, Halperin D, McFarland W, YWS Study Investigators Group. Young Women's Survey. Anal intercourse among young low-income women in California: an overlooked risk factor for HIV? AIDS 2001; 15: 534-535.